Everyone's journey is different and some people choose to share, some overshare, and some don't want to discuss it at all. I'm an open book, and I try to educate others as much as I can.

Positive results for Intellia Therapeutics, Inc.'s NTLA-2002 in treating HAE patients. Stock price dips, but the program ...

Intellia has reported positive results from its ongoing Phase I/II trial of NTLA-2002, a CRISPR-based gene editing therapy ...

Woman tropical massage facial beauty treatment. getty. While vacations are relaxing, the days before a trip are famously busy ...

While the makeup of the Franchise Times Top 400 Health & Medical category is changing, with regenerative therapy, mental ...

Grace Therapeutics will begin trading on Nasdaq under the trading symbol "GRCE" effective October 28, 2024 ...

Vyalev, also known as Produodopa, has been approved in 35 countries, with more than 4200 patients having started treatment.

What you need to know Intravenous thrombolytics, including the recombinant tissue plasminogen activators alteplase or ...

A single dose of the CRISPR-based gene-editing therapy NTLA-2002 reduced angioedema attacks and led to sustained reduction in ...

Global genomic data sharing enhances precision medicine. In this Roadmap, the authors outline evolving data-sharing models, best practices and policy impacts, and propose 12 actions to ...

Tracking patient response to DMARD therapy has the potential to improve remission, but multiple barriers must be overcome ...

An oncology nurse from Dana-Farber Cancer Institute exudes the definition of an extraordinary healer, according to three ...